Therefore, zonulin could be proposed not just as a marker of altered intestinal permeability in children and adolescents with overweight and obesity but also as a possible indicator of metabolism dysregulation helping to identify patients at increased risk of developing T2DM worthy of early and targeted preventive and therapeutic interventions. The gene discussed is HP; the disease is obesity disorder.